Arix Bioscience plc: Amplyx Unveils Expanded Pipeline and Reports Phase 2 Data from Lead Programme

Corporate Breaking News

Home : Arix Bioscience plc: Amplyx Unveils Expanded Pipeline and Reports Phase 2 Data from Lead Programme

Sep 17 2019	Arix Bioscience plc: Amplyx Unveils Expanded Pipeline and Reports Phase 2 Data from Lead Programme
LONDON, Sept. 17, 2019 /PRNewswire/ -- Arix Bioscience plc (LSE: ARIX) ("Arix"), a global venture capital company focused on investing in and building breakthrough biotech companies, today notes the following updates from its portfolio company Amplyx Pharmaceuticals ("Amplyx"), a biotech...


Source:https://www.prnewswire.com:443/news-releases/arix-bioscience-plc-amplyx-unveils-expanded-pipeline-and-reports-phase-2-data-from-lead-programme-300919410.html

Related News
» US Equities consensus points towards a bullish tone - AssetPulse September 2019 » Letter from the CEO to Sony's Shareholders and All Stakeholders